Prof. RICCARDO CAPPATO | CARDIOLOGIA | Best Researcher Award
DIRETTORE, IRCCS MULTIMEDICA, Italy
As a renowned cardiologist and medical director, I have dedicated my career to advancing the field of arrhythmias and electrophysiology. With extensive experience in research and clinical practice, I have made significant contributions to the development of innovative treatments for cardiac conditions. My work has been recognized globally, and I have held leadership positions in prestigious medical organizations.
Profile
🎓Education
I earned my Degree in Medicine and Surgery with honors from the University of Ferrara, Italy. I later specialized in Cardiology with a grade of 70/70 with honors from the same university. I also obtained ECFMG Certification for clinical practice in the United States.
👨🔬 Experience
I have held various leadership positions, including Medical Director and Cardiologist at several prominent hospitals in Italy, such as IRCCS MULTIMEDICA Group and HUMANITAS RESEARCH HOSPITAL. I have also been a Professor at HUMANITAS UNIVERSITY HU and have extensive research experience.
🔍 Research Interest
I have received several awards for my contributions to cardiology, including the ANMCO “G. Binda” Award for Scientific Research and the Boehringer Ingelheim Italy Award for Cardiac Research. I was also recognized with the National Award “L’altra Italia: Vite da Premio” for my work.
🏆 Awards
My research focuses on arrhythmias and electrophysiology, with a particular emphasis on catheter ablation of atrial fibrillation and the use of implantable defibrillators. I have published numerous studies and guidelines in prestigious journals and have participated in research on the efficacy and safety of cardiac ablation.
📚 Publications
1. HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017) 💊
2. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation (2018) 📊
3. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation (2010) 💻
4. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest (2007) 💊
5. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation (2000) 🌐
6. Task force on sudden cardiac death of the European Society of Cardiology (2005) 📝
7. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials (2001) 📊
8. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation (2019) 💊
9. An entirely subcutaneous implantable cardioverter–defibrillator (2019) 💻
10. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation (2010) 📊
11. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp (2009) 💊
12. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system (2002) 💻
13. Subcutaneous only implantable cardioverter defibrillator and optional pacer (US Patent 6,721,597)
Conclusion
The researcher demonstrates a strong foundation for the Best Researcher Award, with academic excellence, clinical experience, and professional memberships. While there are areas for improvement, such as increasing research output and international collaborations, the researcher’s contributions to cardiology and leadership roles make them a compelling candidate for this award.